The 1st newsletter on the INCOVER H2020 project is now available
28.06.2017iBET is one of the partners in this EU funded project which aims to develop Innovative Eco-Technologies for Resource Recovery from Wastewater
Merck Portugal sponsors the purchase of a new Protein Crystallization Robot by iBET
22.06.2017This is a key instrument in the continued partnership between the Structural Biology for Drug Discovery Unit at iBET in Oeiras and the Molecular Interactions and Biophysics Group at Merck in Darmstadt.
iBET on the National TV news: An innovative clinical trial and the first in Europe with stem cell infusion for cardiac regeneration
12.06.20171st year results prove to be very promising: no adverse effects or rejection of the cells were observed in the 55 patients tested!
Paula Alves nominated President of the European Society of Animal Cell Technology
29.05.2017The nomination was announced during its 25th Meeting, held last May in Lausanne, Switzerland.
iBET was the largest delegation attending the 25th ESACT Meeting
25.05.2017The 2017 ESACT (European Society of Animal Cell Technology) Meeting took place in Lausanne (May 14-17) and focused on the theme "Cell technologies for innovative therapies".
iBET was present at the XVI Portuguese Congress of Nutrition and Food (4-5 May) at the invitation of its shareholder Buggypower
08.05.2017The meeting joined together over 1500 nutritionists, researchers, MDs and other professionals from the agrofood industry to debate topics aligned with inovation, new food sources, metabolic disorders and healthy aging.
Buggypower becomes iBET's most recent shareholder
20.04.2017Buggypower is a biotechnology company specialized in the design, construction and operation of microalgae production units.
Rosário Bronze is the new Head of iBET’s Food & Health Division
19.04.2017Rosário Bronze, Associate Professor at the School of Pharmacy of the University of Lisbon (FFUL), is head of the Food Functionality and Bioactives Lab at iBET and ITQB NOVA and of the Toxicological and Bromatology Lab at FFUL.
iBET participates in the recently EC-awarded project “TRANSVAC2”
19.04.2017The EC has officially approved the “TRANSVAC2” project. This project has as coordinating institution the European Vaccine Initiative (EWIV) and a maximum grant amount of 10 M€ for 60 months.
GenIbet joins iBET as shareholder
01.04.2017Genibet is a CDMO (Contract Development and Manufacturing Organization) created in 2006, with headquarters in Oeiras and that is dedicated to the manufacture of biopharmaceutical products.